Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.
作者： Julie Lemieux , Michael D. Brundage , Wendy R. Parulekar , Paul E. Goss , James N. Ingle
关键词: Adjuvant therapy 、 Aromatase inhibitor 、 Placebo 、 Letrozole 、 Internal medicine 、 Breast cancer 、 Cancer 、 Medicine 、 Randomized controlled trial 、 Quality of life
摘要: PurposeMA.17R was a Canadian Cancer Trials Group–led phase III randomized controlled trial comparing letrozole to placebo after 5 years of aromatase inhibitor as adjuvant therapy for hormone receptor–positive breast cancer. Quality life (QOL) secondary outcome measure the study, and here, we report results these analyses.MethodsQOL measured using Short Form-36 (SF-36; two summary scores eight domains) menopause-specific QOL (MENQOL; four symptom at baseline every 12 months up 60 months. assessment mandatory Group centers but optional in other groups. Mean change from were calculated.ResultsOne thousand nine hundred eighteen women randomly assigned, 1,428 completed assessment. Compliance with measures > 85%. Baseline SF-36 physical component (47.5 47.9 placebo) mental (55.5 let...
elsevier.com
sci-hub.se 参考文章(13)
Andrea Will, Michaela Rancea, Ina Monsef, Achim Wöckel, Andreas Engert, Nicole Skoetz, Mindfulness-based stress reduction for women diagnosed with breast cancer Cochrane Database of Systematic Reviews. ,vol. 3, ,(2015) , 10.1002/14651858.CD011518
A Mchomey Colleen, John E Ware Jr, ER Anastasia, The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care. ,vol. 31, pp. 247- 263 ,(1993) , 10.1097/00005650-199303000-00006
Elizabeth Maunsell, Paul E. Goss, Rowan T. Chlebowski, James N. Ingle, José E. Alés-Martínez, Gloria E. Sarto, Carol J. Fabian, Pascal Pujol, Amparao Ruiz, Andrew L. Cooke, Susan Hendrix, Debra W. Thayer, Kendrith M. Rowland, Pierre Dubé, Silvana Spadafora, Sandhya Pruthi, Lavina Lickley, Susan L. Ellard, Angela M. Cheung, Jean Wactawski-Wende, Karen A. Gelmon, Dianne Johnston, Andrea Hiltz, Michael Brundage, Joseph L. Pater, Dongsheng Tu, Harriet Richardson, Quality of life in MAP.3 (Mammary Prevention 3): A randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer Journal of Clinical Oncology. ,vol. 32, pp. 1427- 1436 ,(2014) , 10.1200/JCO.2013.51.2483
David Osoba, Andrea Bezjak, Michael Brundage, Benny Zee, Dongsheng Tu, Joseph Pater, Quality of Life Committee of the NCIC CTG, Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group European Journal of Cancer. ,vol. 41, pp. 280- 287 ,(2005) , 10.1016/J.EJCA.2004.10.017
Wilma M Hopman, Claudie Berger, Lawrence Joseph, Tanveer Towheed, Elizabeth VandenKerkhof, Tassos Anastassiades, Jonathan D Adachi, George Ioannidis, Jacques P Brown, David A Hanley, Emmanuel A Papadimitropoulos, CaMos Research Group, None, The natural progression of health-related quality of life: results of a five-year prospective study of SF-36 scores in a normative population. Quality of Life Research. ,vol. 15, pp. 527- 536 ,(2006) , 10.1007/S11136-005-2096-4
Ron D. Hays, Cathy Donald Sherbourne, Rebecca M. Mazel, The rand 36-item health survey 1.0 Health Economics. ,vol. 2, pp. 217- 227 ,(1993) , 10.1002/HEC.4730020305
Eleftherios P Mamounas, Jong-Hyeon Jeong, D Lawrence Wickerham, Roy E Smith, Patricia A Ganz, Stephanie R Land, Andrea Eisen, Louis Fehrenbacher, William B Farrar, James N Atkins, Eduardo R Pajon, Victor G Vogel, Joan F Kroener, Laura F Hutchins, André Robidoux, James L Hoehn, James N Ingle, Charles E Geyer Jr, Joseph P Costantino, Norman Wolmark, None, Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial Journal of Clinical Oncology. ,vol. 26, pp. 1965- 1971 ,(2008) , 10.1200/JCO.2007.14.0228
Lawrence Joseph, Claudie Berger, Wilma M. Hopman, Alan Tenenhouse, Timothy M. Murray, David A. Hanley, Canadian normative data for the SF-36 health survey Canadian Medical Association Journal. ,vol. 163, pp. 265- 271 ,(2000)
Timothy J. Whelan, Paul E. Goss, James N. Ingle, Joseph L. Pater, Dongsheng Tu, Kathleen Pritchard, Shifang Liu, Lois E. Shepherd, Michael Palmer, Nicholas J. Robert, Silvana Martino, Hyman B. Muss, Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women Journal of Clinical Oncology. ,vol. 23, pp. 6931- 6940 ,(2005) , 10.1200/JCO.2005.11.181
Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen E. Gelmon, Sharon H. Giordano, Clifford A. Hudis, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs, Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression Journal of Clinical Oncology. ,vol. 34, pp. 1689- 1701 ,(2016) , 10.1200/JCO.2015.65.9573